Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.4 USD | 0.00% | -57.96% | -85.73% |
Apr. 17 | TD Cowen Adjusts Price Target on Pacific Biosciences of California to $2.50 From $12, Maintains Buy Rating | MT |
Apr. 16 | Sector Update: Health Care Stocks Higher Late Afternoon | MT |
- Stock Market
- Equities
- PACB Stock
- News Pacific Biosciences of California, Inc.